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Abstract
Background: Capsule endoscopy (CE) is a unique tool to visualize the mucosa of the small
intestine. Chronic intestinal dysmotility (CID) is a group of rare disorders of gastrointestinal
motility that often are complicated by bacterial overgrowth. The aim of this study was to determine
the prevalence of small bowel mucosal abnormalities in patients with CID. We also studied the
usefulness of CE in the diagnosis of intestinal dysmotility.
Methods: We conducted a prospective study using CE in 18 patients; six with myopathic, 11 with
neuropathic and one with indeterminate CID. A control group was used for comparison of small
bowel transit.
Results: Mucosal breaks (erosions and ulcerations) were found in 16/18 (89%) patients. The
capsule reached the caecum in 11/18 (61%) patients with a median transit time of 346 minutes. In
the control group the capsule reached the caecum in 29/36 (81%) cases with a median transit time
of 241 minutes. The difference in transit time was not significant (p = 0.061) in this material. The
capsule was retained in the stomach in 3/18 patients. None of the patients developed symptoms or
signs of mechanical obstruction.
Conclusion: A high frequency of mucosal breaks and signs of motility disturbances were seen in
CID patients. CE is feasible for the examination of small bowel mucosa in patients with CID. The
relevance of observed mucosal abnormalities in CID remains uncertain.
Background
Chronic intestinal dysmotility (CID) is a syndrome that is
characterized by symptoms and signs of intestinal
obstruction in the absence of a mechanical blockage [1].
CID is caused by abnormalities in the intestinal smooth
muscle or the myenteric plexus, usually affecting selec-
tively one of them [2]. The underlying pathology in CID
is thus believed to comprise two major types: myopathic
and neuropathic disorders, although they usually present
with similar clinical manifestations [3]. There is consider-
able confusion regarding the nomenclature in gastrointes-
tinal motility disorders. Patients with CID can also be
divided into those with chronic intestinal pseudo-
obstruction (CIP) and those with enteric dysmotility (ED)
[4]. At present the possible medical or surgical treatment
for this complex and often debilitating syndrome is lim-
ited [1,5,6].
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Wireless capsule endoscopy (CE) is a method to examine
the mucosa of the small intestine. The patient swallows a
small capsule containing a video camera that takes two
frames per second during its journey through the gastroin-
testinal tract. It is propelled by peristalsis and disposable.
This method, first described by Iddan et al [7], is now
widespread and has revolutionized the visualisation of
small intestinal mucosa.
Previously CID has been considered a contraindication
for CE [8-10]. In the literature there is only one published
original article where capsule endoscopy has been per-
formed in patients with CID [11]. In this study six patients
were examined and found to have a high frequency of
mucosal breaks. The knowledge of the appearance of the
mucosa in vivo in this condition is therefore incomplete
and the experience of performing CE in patients with CID
seems to be limited.
In this prospective study we examined patients with
known CID by means of CE. The primary aim of our study
was to evaluate the small bowel mucosa of patients with
CID. A secondary aim was to find out if CE, by evaluating
small bowel transit and signs of dysmotility, could differ-
entiate the two histopathological types of CID from each
other and from a control group.
Methods
Eighteen patients with CID were examined with CE for the
purpose of this study. The patients had a well documented
motility disorder. Their diagnosis was based on clinical
features, x-ray findings, small-bowel manometry and
intestinal full thickness biopsy. Six of them had myo-
pathic CID, 11 had neuropathic CID and one had indeter-
minate CID. Their ages ranged between 35–85 (median
54) years. There were 6 males and 12 females. One female
had a previous history of gastro-intestinal bleeding,
whereas the others had no such history.
Including intestinal full thickness biopsy the patients had
undergone abdominal surgical interventions 1–10
(median 2) times (Table 1). Surgery had been performed
for different reasons including cholecystectomy, appen-
dectomy and gynaecological interventions. In five cases
(#11, #12, #14, #16, #18) surgery was aimed at treating
the underlying motility disorder and consisted mainly of
bowel resections.
No drugs that could interfere with motility were allowed
for 48 hours before examination. Non steroid anti-inflam-
matory drugs (NSAIDs) were not allowed but one of the
patients (#17) was later found out to have been using this
at the time for capsule endoscopy. The patients had only
liquid food on the evening before and no oral intake at all
from midnight before examination. No bowel prepara-
tion was given. The capsule (PillCam, Given Imaging) was
swallowed with two glasses of water.
The capsule takes two images per second during eight
hours, depending on battery power. The frames are trans-
mitted directly to a recorder and after the examination
they are unloaded onto a computer were the approxi-
mately 50,000 frames can be viewed one by one or as a
video sequence.
The results from the CE examinations were viewed by two
of us, first separately and then together. Only findings that
both agreed to be significant were recorded as present. The
readers were blinded for the type of CID the patients were
suffering from as well as all other clinical information.
If the capsule did not reach the caecum during the record-
ing time, complete small intestinal passage was controlled
by means of fluoroscopy, which was carried out within a
week after the examination.
In order to evaluate small bowel transit in the study cases,
a control group was used. The control group consisted of
36, randomly selected, age and gender matched patients
who previously had underwent capsule endoscopy at our
centre, between 2003 and 2005, because of occult gas-
trointestinal bleeding. The controls had been viewed by
the same two readers as the study group and the original
results concerning small bowel transit were used. The
patients had no symptoms of intestinal obstruction or his-
tory of motility disorder. The CE procedure, including
bowel preparation, was the same in both groups.
Statistical analysis
Median values with ranges were used in the text. We used
Kaplan-Meier plots and the log-rank test for the analysis of
small bowel transit times.
Ethical consideration
This study was approved by The Research Ethics Commit-
tee of Karolinska Institutet, Stockholm, Sweden. The par-
ticipants were given oral and written information and
have given their consent orally.
Results
All patients underwent the examination without compli-
cations. None of them developed symptoms of intestinal
obstruction during the examination and no one needed
endoscopical or surgical removal of the capsule. The
results are presented in detail in Table 1.
Three patients retained the capsule in the stomach
(defined in this study as more than two hours in the stom-
ach), one of them for the whole recording time. That
patient underwent a new CE with endoscopic placementBMC Gastroenterology 2007, 7:29 http://www.biomedcentral.com/1471-230X/7/29
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of the capsule in the duodenum and the second capsule
reached caecum within recording time. One patient had
retention of the capsule in the oesophagus for 20 minutes.
The capsule reached the caecum during the eight-hour
recording time in 11/18 (61%) patients. In patients with
myopathic CID the capsule reached the caecum during
the recording time in only 2/6 patients, despite that only
one had a gastric retention. In the control group the cap-
sule reached the caecum in 29/36 (81%) patients. When
the capsule did not reached the caecum during the record-
ing time, the examination was considered as incomplete
and the small bowel transit time was estimated to >400
min. The median transit time in neuropathic CID was 305
(197 – >400) minutes whereas in myopathic CID the
median transit time was >400 (219 – >400) minutes (p =
0.051). In the whole study group median transit time was
346 (197 – >400) minutes, whereas in the control group
it was 241 (75 – >400) minutes (p = 0.061).
The view was considered as clear with little or no intesti-
nal content in only 10/18 (56%) patients. In cases where
the view was reduced the reason was mainly large
amounts of intestinal content. In the control group the
view was considered as clear in 30/36 (83%) patients.
Mucosal breaks were found in 16/18 (89%) patients and
in seven patients there were multiple lesions (three or
more). The mucosal breaks were divided into erosions
and ulcerations. The findings defined as erosions included
not only redness but also some loss of mucosa (Figure 1)
and often could a small fibrin clot be seen. Ulcerations, on
the other hand, were larger, deeper and covered with
fibrin (Figure 2). Erosions were the dominating type of
mucosal breaks that was found. At most, one patient had
19 erosions. In patient #17, eight ulcerations were found.
This patient, however, was found to have used NSAIDs
during the period before CE examination. The exact size
and localization of lesions are not possible to determine
by means of CE and subsequently not in this study group
either.
Other findings included angiodysplasias and flebectasias.
In patient #16, who had a history of occult gastrointesti-
nal bleeding, multiple angiodysplasias were found. Two
of the patients showed signs of inflammation with swol-
len villi and reddish mucosa.
Discussion
This is a descriptive study in a limited number of patients,
but so far the largest systematic study using capsule endos-
copy in patients with chronic intestinal dysmotility pre-
sented in the literature.
The capsule reached the caecum in 61% of the patients
compared to 81% in the control group. Previous studies
in mixed patient groups have found passage to the caecum
in 75–95% [8,12-19]. In the literature mean transit time
is usually measured in studies comparing bowel prepara-
tion and the use of pro-kinetic drugs, and varies between
Table 1: Clinical characteristics and results of capsule endoscopy in 18 patients with chronic intestinal dysmotility.
Nr Gender/Age Type of CID Previous Abdom. Surgery View (1) Caecum (2) Transit time (3) Retention (4) Ulcers Erosions Miscellanous
1 M/39 Myopathy 2 Clear Yes 378 19
2 M/59 Myopathy 3 Poor No 2 Inflam (6)
3 M/46 Myopathy 1 Med Yes 219 S 165 1
4 F/41 Myopathy 2 Poor No 1
5 F/72 Myopathy 2 Med No 2 Angiodysplas
ia
6 M/85 Myopathy 1 Poor No O 20 1
7 F/52 Neuropathy 2 Clear Yes 305 4
8 F/59 Neuropathy 2 Clear Yes 353 S 480 5 CE × 2 (7)
9 M/49 Neuropathy 4 Clear Yes 363 2
10 F/56 Neuropathy 2 Clear Yes 209 S 180 1
11 F/36 Neuropathy 4 (5) Clear Yes 197 2
12 F/65 Neuropathy 2 (5) Med No 10
13 F/47 Neuropathy 3 Poor Yes 335
14 F/35 Neuropathy 6 (5) Poor No 3
15 F/65 Neuropathy 1 Clear Yes 227 1 Inflam
16 F/57 Neuropathy 10 (5) Clear Yes 286 Angiodysplas
ia Flebectesia
17 F/40 Neuropathy 4 Clear Yes 338 8 10
18 M/69 Indeterminate 6 (5) Clear No 6
(1) Clear = Clear view, small amounts of intestinal content. Med = Medium view, some intestinal content hiding parts of the mucosa. Poor = Poor view, large amounts of 
intestinal content hiding a considerable part of the mucosa.
(2) The capsule reached caecum within recording time.
(3) Transit time in small intestine in minutes.
(4) O = oesophagus, S = stomach, retention measured in minutes.
(5) Surgery included intestinal resections.
(6) Inflam = Inflammation, signs of villus oedema and redness.
(7) First capsule was retained in the stomach.BMC Gastroenterology 2007, 7:29 http://www.biomedcentral.com/1471-230X/7/29
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218 and 255 minutes [14-18]. Since mean transit time
was not possible to determine in this study, because of the
large number of incomplete examinations, where transit
time only was known to be 400 minutes or more, we
chose to use median transit time instead. A tendency
towards prolonged transit time was seen in CID patients
compared to controls.
When the capsule does not reach the caecum during the
recording time, the diagnostic yield of CE may be
decreased [19]. Large amounts of intestinal content may
also impair the view and lead to a higher risk for overlook-
ing lesions, thus decreasing the diagnostic yield of CE.
Despite these limitations, we found that 89% of the
patients had mucosal breaks and this was an unexpected
finding. Forty-four percent (8/18) of our patients had
three or more erosions or deeper lesions that were classi-
fied as ulcers. In a group of 413 healthy volunteers who
underwent CE, Goldstein et al [20] found mucosal breaks
in only 14%. One of our patients with multiple ulcers was
later found out to have been using NSAIDs when perform-
ing the examination and this is a well-known cause for
ulcers in the small intestine [20-23]. The other patients
had no obvious reason for presenting mucosal breaks. The
reasons for the large proportion of mucosal breaks in this
study are only speculative. One possible explanation is
that the mucosal breaks are due to bacterial overgrowth,
which is common in CID as a complication of the
impaired transit [24].
Comparing the two histopathological groups of CID was
difficult because of the limited size of the study group and
its dominance of neuropathic cases. A prolonged median
transit time was seen in the myopathic group but the dif-
ference did not quite reach statistical significance (p =
0.051). Patients with myopathic CID had more often
large amount of intestinal content and because of that,
did not present a clear view in half of the cases. No differ-
ences regarding mucosal breaks could be noticed between
the two groups.
Motility disturbances are thus detectable by means of CE
although the method was unable to confirm the diagnosis
or differentiate between the two forms of CID in this
study. CE will probably not be a first line examination
tool in diagnosing CID but might be indicated in selective
cases.
As mentioned in the introduction CID has been consid-
ered as a contraindication for CE. The reason for this
should be the supposed high risk for capsule retention.
Patients diagnosed with CID have been thoroughly exam-
ined without findings of narrowing strictures and per def-
inition they do not have mechanical obstruction. On the
other hand traditional x-ray methods like small bowel fol-
low through and enteroclysis have recently been shown to
have a low sensitivity for intestinal strictures [13,17,25-
Erosion Figure 1
Erosion. Erosion in the small intestine, detected by capsule 
endoscopy in a patient with chronic intestinal dysmotility and 
large amounts of intestinal content.
Ulcer Figure 2
Ulcer. Ulcer in the small intestine as seen by capsule endos-
copy in a patient with chronic intestinal dysmotility.BMC Gastroenterology 2007, 7:29 http://www.biomedcentral.com/1471-230X/7/29
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28]. If the lumen is narrowed because of a lesion the cap-
sule might be permanently retained (defined as retention
> 2 weeks) and surgical or endoscopic removal becomes
necessary. Permanent retention is reported to occur in 0 to
13% of all CE procedures, depending on the definition for
capsule retention and how the patients were selected
[12,13,25-31]. In recent years CE has been performed in a
large number of patients with known or suspected
Crohn's disease [26,28,29,32] and even in some cases
with suspected or known strictures [26,28]. However
there are, to our knowledge, only two cases of acute small
bowel obstruction requiring acute surgery following a CE
procedure published in the literature [27,29].
Permanent capsule retention is generally due to a lesion
that has given rise to the underlying symptoms and surgi-
cal intervention leads in most cases to an improvement of
the clinical situation [13,19,26,28-30]. If this statement
also is true for patients with CID is yet unproven. In our
study no patient had a permanent retention though suf-
fering from massive obstructive symptoms. We believe
that CE can be performed in patients with CID under the
same conditions as other patients with obstructive symp-
toms; i.e. the patient must be made fully aware that surgi-
cal intervention may become necessary in the case of
finding an obstructive lesion.
Conclusion
Capsule endoscopy can be performed in patients with sus-
pected or confirmed chronic intestinal dysmotility.
Mucosal breaks, mainly in form of erosions and in a few
cases ulcerations, were found in 16 of 18 patients. The rel-
evance of the observed mucosal abnormalities remains
uncertain. We hypothesize that mucosal erosions and
ulcers in CID may be due to bacterial overgrowth.
Impaired motor activity was shown by a high frequency of
stomach retentions, prolonged intestinal transit times,
large amounts of intestinal content and frequent failure of
the capsule to reach the caecum. Small bowel transit times
did not significantly differ between myopathic and neuro-
pathic CID, or to a control group in this study. Capsule
endoscopy might be useful in selective cases of CID and
when concomitant or a coexisting disorder in the small
intestine is suspected.
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